PARKE DAVIS FDA Approval NDA 016768

NDA 016768

PARKE DAVIS

FDA Drug Application

Application #016768

Application Sponsors

NDA 016768PARKE DAVIS

Marketing Status

Discontinued002
Discontinued003

Application Products

002TABLET;ORAL0.1MG0ESTROVISQUINESTROL
003TABLET;ORAL0.2MG0ESTROVISQUINESTROL

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1996-04-26STANDARD
LABELING; LabelingSUPPL2AP1996-04-26
EFFICACY; EfficacySUPPL4AP1996-04-26
EFFICACY; EfficacySUPPL5AP1996-04-26
EFFICACY; EfficacySUPPL6AP1996-04-26
LABELING; LabelingSUPPL9AP1996-04-26
LABELING; LabelingSUPPL10AP1996-04-26

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 16768
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.